Ardea raises $77.1 million in public offering
This article was originally published in Scrip
Executive Summary
Ardea Biosciences completed a public offering, raising net proceeds of around $77.1 million. The US firm issued 3.5 million shares to investors at $20 each plus an additional 525,000 shares to the underwriter Jefferies & Company at $19.15 apiece.